Stocks and Investing
Stocks and Investing
Tue, March 20, 2018
[ 12:00 AM ] - United States, WOPRAI
Mon, March 19, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Holford Upgraded (AZN) to Strong Buy on, Mar 19th, 2018
Jeffrey Holford of Jefferies, Upgraded "AstraZeneca PLC" (AZN) to Strong Buy on, Mar 19th, 2018.
Jeffrey has made no other calls on AZN in the last 4 months.
There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, all agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Seamus Fernandez of "Leerink Swann" Maintained at Hold with Increased Target to $38 on, Tuesday, February 6th, 2018
Contributing Sources